Urinary Tract Cancer Clinical Trial
Official title:
An Open Label, Single Arm, Multicenter, Safety Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
This Phase IIIb, multicenter study will assess the safety of atezolizumab as second- to fourth-line treatment for participants with locally advanced or metastatic urothelial or non-urothelial cancer of the urinary tract in addition to evaluate the efficacy of atezolizumab and potential tumor biomarkers associated with atezolizumab.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05544552 -
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02379429 -
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
|
||
| Recruiting |
NCT05038657 -
Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
|
Phase 2 | |
| Completed |
NCT04430842 -
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
|
Phase 1 | |
| Recruiting |
NCT04718948 -
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
|
||
| Completed |
NCT02006667 -
A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer
|
Phase 2 | |
| Terminated |
NCT02013765 -
A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer
|
Phase 2 | |
| Completed |
NCT03410641 -
Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study
|
N/A | |
| Completed |
NCT03013920 -
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
|